Pablo Romero-Clavijo
-
- Cancer Immunotherapy and Biomarkers 1
- Cancer Treatment and Pharmacology 1
-
- Protein Kinase Regulation and GTPase Signaling 1
- PI3K/AKT/mTOR signaling in cancer 1
-
- Immunotherapy and Immune Responses 1
-
- Inflammatory mediators and NSAID effects 1
-
- Adenosine and Purinergic Signaling 1
-
- Monoclonal and Polyclonal Antibodies Research 1
- Co-authors
- Julian DownwardMíriam Molina‐ArcasSareena RanaEdurne MugarzaFebe van MaldegemChristopher MooreEleanor HerbertMatthew R. Janes
- Cited by
- OncologyMolecular BiologyImmunology
- Partner nations
- United Kingdom
In The Last Decade
Pablo Romero-Clavijo
3 papers receiving 218 citations
Peers
Comparison fields: 5 of 38
- Oncology 107
- Molecular Biology 149
- Immunology 44
- Pulmonary and Respiratory Medicine 54
- Cancer Research 22
Countries citing papers authored by Pablo Romero-Clavijo
This map shows the geographic impact of Pablo Romero-Clavijo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pablo Romero-Clavijo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pablo Romero-Clavijo more than expected).
Fields of papers citing papers by Pablo Romero-Clavijo
This network shows the impact of papers produced by Pablo Romero-Clavijo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pablo Romero-Clavijo. The network helps show where Pablo Romero-Clavijo may publish in the future.
Co-authorship network
The 16 scholars most cited alongside Pablo Romero-Clavijo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 73 | |
| 2 | 2022 | 1 | |
| 3 | 2019 | 146 |
About Pablo Romero-Clavijo
Pablo Romero-Clavijo is a scholar working on Physiology, Oncology and Pharmacology, having authored 3 papers that have together received 220 indexed citations. Recurring topics across this work include Inflammatory mediators and NSAID effects (1 paper), Protein Kinase Regulation and GTPase Signaling (1 paper), Adenosine and Purinergic Signaling (1 paper), Monoclonal and Polyclonal Antibodies Research (1 paper), Cancer Immunotherapy and Biomarkers (1 paper), Immunotherapy and Immune Responses (1 paper), Cancer Treatment and Pharmacology (1 paper) and PI3K/AKT/mTOR signaling in cancer (1 paper). The work is most often cited by research in Oncology (107 citations), Molecular Biology (149 citations) and Immunology (44 citations). Pablo Romero-Clavijo has collaborated with scholars based in United Kingdom. Frequent co-authors include Julian Downward, Míriam Molina‐Arcas, Sareena Rana, Edurne Mugarza, Febe van Maldegem, Christopher Moore, Eleanor Herbert, Matthew R. Janes, Lian‐Sheng Li and Stuart Horswell.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.